Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis

L Liao1, D F Kong, Z Samad

  • 1Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA. liao0002@mc.duke.edu

Summary

Echocardiography-guided risk stratification for infective endocarditis (IE) surgery is cost-effective, improving patient outcomes for an incremental cost under $50,000 per quality-adjusted life year (QALY). This strategy is particularly beneficial for patients with higher baseline stroke risks.